Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance - PubMed (original) (raw)
. 1991 Mar 15;266(8):4706-12.
Affiliations
- PMID: 2002019
Free article
Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance
S Marshall et al. J Biol Chem. 1991.
Free article
Abstract
Based on our previous finding that desensitization of the insulin-responsive glucose transport system (GTS) requires three components, glucose, insulin, and glutamine, we postulated that the routing of incoming glucose through the hexosamine biosynthesis pathway plays a key role in the development of insulin resistance in primary cultured adipocytes. Two approaches were used to test this hypothesis. First, we assessed whether glucose-induced desensitization of the GTS could be prevented by glutamine analogs that irreversibly inactivate glutamine-requiring enzymes, such as glutamine:fructose-6-phosphate amidotransferase (GFAT) the first and the rate-limiting enzyme in hexosamine biosynthesis. Both O-diazoacetyl-L-serine (azaserine) and 6-diazo-5-oxonorleucine inhibited desensitization in 18-h treated cells without affecting maximal insulin responsiveness in control cells. Moreover, close agreement was seen between the ability of azaserine to prevent desensitization of the GTS in intact adipocytes (70% inhibition, ED50 = 1.1 microM), its ability to inactivate GFAT in intact adipocytes (64% inhibition, ED50 = 1.0 microM) and its ability to inactivate GFAT activity in a cytosolic adipocyte preparation (ED50 = 1.3 microM). From these results we concluded that a glutamine amidotransferase is involved in the induction of insulin resistance. As a second approach, we determined whether glucosamine, an agent known to preferentially enter the hexosamine pathway at a point distal to enzymatic amidation by GFAT, could induce cellular insulin resistance. When adipocytes were exposed to various concentrations of glucosamine for 5 h, progressive desensitization of the GTS was observed (ED50 = 0.36 mM) that culminated in a 40-50% loss of insulin responsiveness. Moreover, we estimated that glucosamine is at least 40 times more potent than glucose in mediating desensitization, since glucosamine entered adipocytes at only one-quarter of the glucose uptake rate, yet induced desensitization at an extra-cellular dose 10 times lower than glucose. In addition, we found that glucosamine-induced desensitization did not require glutamine and was unaffected by azaserine treatment. Thus, we conclude that glucosamine enters the hexosamine-desensitization pathway at a point distal to GFAT amidation. Overall, these studies indicate that a unique metabolic pathway exists in adipocytes that mediates desensitization of the insulin-responsive GTS, and reveal that an early step in this pathway involves the conversion of fructose 6-phosphate to glucosamine 6-phosphate by the first and rate-limiting enzyme of the hexosamine pathway, glutamine:fructose-6-phosphate amidotransferase.
Similar articles
- The hexosamine biosynthetic pathway and glucose-induced down regulation of glucose transport in L6 myotubes.
Davidson MB, Hunt K, Fernandez-Mejia C. Davidson MB, et al. Biochim Biophys Acta. 1994 Sep 28;1201(1):113-7. doi: 10.1016/0304-4165(94)90159-7. Biochim Biophys Acta. 1994. PMID: 7918574 - Hexosamines, insulin resistance, and the complications of diabetes: current status.
Buse MG. Buse MG. Am J Physiol Endocrinol Metab. 2006 Jan;290(1):E1-E8. doi: 10.1152/ajpendo.00329.2005. Am J Physiol Endocrinol Metab. 2006. PMID: 16339923 Free PMC article. Review. - Role of the hexosamine biosynthetic pathway in diabetic nephropathy.
Schleicher ED, Weigert C. Schleicher ED, et al. Kidney Int Suppl. 2000 Sep;77:S13-8. doi: 10.1046/j.1523-1755.2000.07703.x. Kidney Int Suppl. 2000. PMID: 10997685 Review.
Cited by
- The roles of OGT and its mechanisms in cancer.
Liu X, Wang J, Xiang Y, Wang K, Yan D, Tong Y. Liu X, et al. Cell Biosci. 2024 Sep 16;14(1):121. doi: 10.1186/s13578-024-01301-w. Cell Biosci. 2024. PMID: 39285476 Free PMC article. Review. - O-GlcNAcylation mediates Wnt-stimulated bone formation by rewiring aerobic glycolysis.
You C, Shen F, Yang P, Cui J, Ren Q, Liu M, Hu Y, Li B, Ye L, Shi Y. You C, et al. EMBO Rep. 2024 Sep 10. doi: 10.1038/s44319-024-00237-z. Online ahead of print. EMBO Rep. 2024. PMID: 39256595 - O-GlcNAcylation in tumorigenesis and its implications for cancer therapy.
Zhang D, Qi Y, Inuzuka H, Liu J, Wei W. Zhang D, et al. J Biol Chem. 2024 Aug 22;300(9):107709. doi: 10.1016/j.jbc.2024.107709. Online ahead of print. J Biol Chem. 2024. PMID: 39178944 Free PMC article. Review. - Critical Role of Preoperative Hyperglycemia in Association with GFAT-1 Expression in Resected Pancreatic Cancer.
Kohara Y, Yasuda S, Nagai M, Nakamura K, Matsuo Y, Terai T, Doi S, Sakata T, Sho M. Kohara Y, et al. Ann Surg Oncol. 2024 Aug 6. doi: 10.1245/s10434-024-15985-4. Online ahead of print. Ann Surg Oncol. 2024. PMID: 39107610 - Chronic rapid eye movement sleep deprivation aggravates the pathogenesis of Alzheimer's disease by decreasing brain O-GlcNAc cycling in mice.
Kim DY, Kim SM, Han IO. Kim DY, et al. J Neuroinflammation. 2024 Jul 23;21(1):180. doi: 10.1186/s12974-024-03179-4. J Neuroinflammation. 2024. PMID: 39044290 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous